Chlamydophila pneumoniae Antibodies IgM (Serum)
The study is designed to detect IgM class antibodies to Chlamydophila pneumoniae — the pathogen of atypical respiratory tract infections.
Used for diagnosing acute or recently experienced chlamydial infection of the respiratory tract.
Most informative in the first weeks of disease, during the period of active immune response.
Prescribed for acute disease onset with pronounced respiratory symptoms.
Applied for early confirmation of the etiology of atypical pneumonias and bronchitis.
What the test assesses:
– Presence or absence of IgM class antibodies to Chlamydophila pneumoniae.
– Acute phase of the infectious process.
– Fact of recent primary infection.
Biomaterial: Venous blood (serum)
– Submit fasting.
– Drinking still water is allowed.
– It is advisable to avoid physical exertion and stress the day before the examination.
Medications:
– It is recommended to submit the test before starting antibacterial therapy.
– Immunoglobulin intake may distort the test result.
– When taking any medications, the attending physician should be notified or the information indicated when submitting the test.
Recommended for testing:
– With fever, cough, symptoms of intoxication, weakness.
– When atypical pneumonia or acute bronchitis with atypical course is suspected.
– With acute or complicated infection course.
– With pronounced respiratory tract infection symptoms in children.
– Positive result (IgM detected): indicates acute or recently experienced Chlamydophila pneumoniae infection.
– Negative result (IgM not detected): acute stage is unlikely; a late disease stage or past infection is possible.
Important — for more precise assessment of disease stage, comprehensive determination of IgM + IgA + IgG, as well as PCR diagnostics, is recommended.
